Point72 (Difc) LTD Day One Biopharmaceuticals, Inc. Put Options Transaction History
Point72 (Difc) LTD
- $2.81 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DAWN
# of Institutions
169Shares Held
73.1MCall Options Held
163KPut Options Held
183K-
Ra Capital Management, L.P. Boston, MA7.87MShares$124 Million1.63% of portfolio
-
Atlas Venture Life Science Advisors, LLC6.43MShares$101 Million11.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.62MShares$72.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$71.4 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.78MShares$59.6 Million0.02% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $1.16B
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...